
FIMM HelsinkiUni
@fimm_uh
Institute for Molecular Medicine Finland FIMM at the HiLIFE, University of Helsinki - Suomen molekyylilääketieteen instituutti (FIMM), Helsingin yliopisto
ID: 3387111231
http://www.fimm.fi 22-07-2015 11:32:12
3,3K Tweet
2,2K Takipçi
438 Takip Edilen

FIMM is seeking a postdoctoral researcher in functional cancer microbiome to join the Arafath (Rafa) Najumudeen lab, in collaboration with Chinmay Dwibedi’s group at MIMS - Molecular Infection Medicine Sweden, through the NORPOD program of the Nordic EMBL P'ship partnership. jobs.helsinki.fi/job/Helsinki-P… #postdocposition #sciencejobs


The Yrjö Jahnsson Foundation awards grants for research in economics, medicine and health economics. The 2024 grants were announced this week. 🎉Warm congratulations to FIMM grant recipients Linda Ottensmann, Lea Urpa, Stephanie Zellers, Felix Vaura & Hannes Frederik Bode! 🔗yjs.fi/myonnetyt-apur…


Killing cancer cells, saving normal ones! Read about our collaboration project with Wennerberg Lab, FIMM HelsinkiUni and the Deciderproject here at EU Research Results: cordis.europa.eu/article/id/454…

FIMM is seeking a Postdoctoral Researcher in Computational Genomics & Machine Learning to join Esa Pitkänen's group, in collaboration with Biswa Sahu, PhD's group at @NCMMnews, through the NORPOD program of the Nordic EMBL P'ship partnership. jobs.helsinki.fi/job/Helsinki-P… #postdocposition #sciencejobs




MSc Anniina Tervi from Hanna M Ollila's group will defend her doctoral dissertation "Environmental Modulation of Genetic Risk for Complex Diseases" on 8 January 2025 at 14:00. Melina Claussnitzer, Ph.D., Harvard University, will serve as the opponent. Welcome! 🔗helsinginyliopisto.etapahtuma.fi/flamma-2019/en…



The December 2024 FIMM Young Investigator of the Month is Hannes Frederik Bode. Warm congratulations to him for his recent first-author publication in Clinical Epigenetics! #doctoraltraining #phdlife


MSc Alina Malyutina will defend her doctoral dissertation entitled: "Exploring drug resistance in multiple myeloma: from multi-omics to treatment suggestion“ on Friday 10 Jan at 12.00. Luciano Cascione (SIB) will serve as the opponent. Welcome! 🔗helsinginyliopisto.etapahtuma.fi/Kalenteri/Engl…



Congratulations on defending your dissertation on the multi-omics analysis of drug resistance in #MultipleMyeloma, Alina! A firm testimony of endurance through hardship. Big thanks to the opponent Dr. Luciano Cascione for making it happen! SIB FIMM HelsinkiUni Orion Pharma #oncosys


The Profi funding instrument supports the strategic profiling of Finnish universities aiming at improving the quality of research. We are happy to participate in one of the three University of Helsinki profiling areas, SWAN: Enhancing Healthy Years, supported by the 30.3 M€ funding!

Excited to have Helena Kilpinen ([email protected]) and special guest Christian Göritz opening the Stem Cell Seminars of 2025 with focus on neurodevelopment, regeneration and fibrotic scarring in the CNS. Jan 23rd 9 am, welcome! @MIBS-Helsinki Institute of Biotechnology (BI) Life Sciences University of Helsinki Medicine and Health, University of Helsinki



Tänä iltana HUS Helsingin yliopistollinen sairaala & Medicine and Health, University of Helsinki järjestämässä Studia Medicina -hybriditapahtumassa aiheena Gynekologiset syövät – uutta toivoa kehittyvillä hoidoilla. Puhujana mm. apulaisprofessori Anniina Färkkilä HiLIFE_Helsinki. Lisätietoja: hus.fi/tapahtumat/stu…


Any eager University of Helsinki BSc / MSc students to join the 2025 Aalto-Helsinki iGEM team? Check the details and apply by Feb 5! HiLIFE EDU is looking forward to yet another year of collaboration! @aaltohelsinki_igem Institute of Biotechnology (BI) FIMM HelsinkiUni @UH_Neuro instagram.com/p/DEkgu-doHil/…


Only a few days left to apply for the NORPOD Postdoctoral Researcher Programme! Don’t miss this rare opportunity to develop a collaborative project under the guidance of 2 group leaders from 2 Nordic EMBL P'ship nodes! #PostdocOpportunity #AcademicCareers 🔗 projects.au.dk/nordic-embl-pa…

Ex vivo venetoclax sensitivity identified treatment responders and correlated with improved outcomes and prolonged survival. Groundbreaking results from the VenEx trial with the Finnish AML Group, University of Helsinki and FIMM HelsinkiUni published now in @BloodJournal